DAX 25.103 -0,1%ESt50 6.270 -0,2%MSCI World 4.851 +0,8%Top 10 Crypto 8,41 +2,8%Nas 26.207 +1,3%Bitcoin 56.329 +1,8%Euro 1,1427 -0,0%Öl 77,0 +1,5%Gold 4.114 -0,2%
Beliebte Suche
DAX 40ÖlpreisEuro - DollarBitcoin - EuroGoldpreis
Meistgesucht
BioNTech (ADRs)A2PSR2TeslaA1CX3TAmazon906866NEL ASAA0B733Microsoft870747Apple865985Siemens EnergyENER6YBASFBASF11NVIDIA918422Lufthansa823212Mercedes-Benz Group (ex Daimler)710000BayerBAY001Daimler TruckDTR0CKPlug PowerA1JA81TUITUAG00
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero.Hier informieren
Top News
Suche...
Jetzt kostenlos
bei finanzen.net anmelden
Watchlists & MusterdepotsTools & integriertes TradingNewsletter, Trading-Desk uvm.
Schon einen Account? Anmelden

EQS-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

Werte in diesem Artikel
Aktien
Dermapharm Holding SE
45.30 EUR 0.00 EUR 0.0 %
Charts | News | Analysen
Aktie kaufen

EQS Preliminary announcement financial reports: Dermapharm Holding SE / Preliminary announcement on the disclosure of financial statements
Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

20.08.2024 / 10:00 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Werbung

Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed:

Report Type: Financial report of the group (half-year/Q2)

Language: German
Date of disclosure: August 27, 2024
Address: https://ir.dermapharm.de/de/investor-relations/#tagline-19857

Language: English
Date of disclosure: August 27, 2024
Address: https://ir.dermapharm.de/en/investor-relations/#tagline-19876

20.08.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: Dermapharm Holding SE
Lil-Dagover-Ring 7
82031 Grünwald
Germany
Internet: ir.dermapharm.de

 
End of News EQS News Service
Werbung

1970107  20.08.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1970107&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6

Aktuelle Dermapharm Aktie News

Werbung

Dermapharm Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Dermapharm nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
27.05.26 Dermapharm Hold Jefferies & Company Inc.
14.05.26 Dermapharm Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
31.03.26 Dermapharm Hold Jefferies & Company Inc.
10.03.26 Dermapharm Hold Jefferies & Company Inc.
10.03.26 Dermapharm Hold Jefferies & Company Inc.